These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28172666)

  • 1. Clinical Impact and Cost-effectiveness of Xpert MTB/RIF Testing in Hospitalized Patients With Presumptive Pulmonary Tuberculosis in the United States.
    Cowan JF; Chandler AS; Kracen E; Park DR; Wallis CK; Liu E; Song C; Persing DH; Fang FC
    Clin Infect Dis; 2017 Feb; 64(4):482-489. PubMed ID: 28172666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xpert MTB/RIF assay shortens airborne isolation for hospitalized patients with presumptive tuberculosis in the United States.
    Lippincott CK; Miller MB; Popowitch EB; Hanrahan CF; Van Rie A
    Clin Infect Dis; 2014 Jul; 59(2):186-92. PubMed ID: 24729506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a Single Xpert MTB/RIF Assay to Determine the Duration of Airborne Isolation in Hospitalized Patients With Suspected Pulmonary Tuberculosis.
    Poonawala H; Leekha S; Medina-Moreno S; Filippell M; Johnson JK; Redfield RR; Saharia KK
    Infect Control Hosp Epidemiol; 2018 May; 39(5):590-595. PubMed ID: 29582718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting.
    Nakiyingi L; Bwanika JM; Ssengooba W; Mubiru F; Nakanjako D; Joloba ML; Mayanja-Kizza H; Manabe YC
    BMC Infect Dis; 2021 Jan; 21(1):63. PubMed ID: 33435896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic challenges and Gene-Xpert utility in detecting Mycobacterium tuberculosis among suspected cases of Pulmonary tuberculosis.
    Kabir S; Parash MTH; Emran NA; Hossain ABMT; Shimmi SC
    PLoS One; 2021; 16(5):e0251858. PubMed ID: 34015016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study.
    Zar HJ; Workman L; Isaacs W; Dheda K; Zemanay W; Nicol MP
    Lancet Glob Health; 2013 Aug; 1(2):e97-e104. PubMed ID: 25104164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-Life Clinical Practice of Using the Xpert MTB/RIF Assay in Thailand.
    Kawkitinarong K; Suwanpimolkul G; Kateruttanakul P; Manosuthi W; Ubolyam S; Sophonphan J; Avihingsanon A; Ruxrungtham K
    Clin Infect Dis; 2017 May; 64(suppl_2):S171-S178. PubMed ID: 28475796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of tuberculosis from smear-negative presumptive TB cases using Xpert MTB/Rif assay: a cross-sectional study from Nepal.
    Khadka P; Thapaliya J; Basnet RB; Ghimire GR; Amatya J; Rijal BP
    BMC Infect Dis; 2019 Dec; 19(1):1090. PubMed ID: 31888522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study.
    Mishra H; Reeve BWP; Palmer Z; Caldwell J; Dolby T; Naidoo CC; Jackson JG; Schumacher SG; Denkinger CM; Diacon AH; van Helden PD; Marx FM; Warren RM; Theron G
    Lancet Respir Med; 2020 Apr; 8(4):368-382. PubMed ID: 32066534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.
    Kay AW; González Fernández L; Takwoingi Y; Eisenhut M; Detjen AK; Steingart KR; Mandalakas AM
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013359. PubMed ID: 32853411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
    Raizada N; Sachdeva KS; Nair SA; Kulsange S; Gupta RS; Thakur R; Parmar M; Gray C; Ramachandran R; Vadera B; Ekka S; Dhawan S; Babre A; Ghedia M; Alavadi U; Dewan P; Khetrapal M; Khanna A; Boehme C; Paramsivan CN
    PLoS One; 2014; 9(8):e105346. PubMed ID: 25140877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of targeted next-generation sequencing and the Xpert MTB/RIF assay for detection of
    Zhang H; Dai X; Hu P; Tian L; Li C; Ding B; Yang X; He X
    Microbiol Spectr; 2024 May; 12(5):e0409823. PubMed ID: 38602399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Added value of molecular assay Xpert MTB/RIF compared to sputum smear microscopy to assess the risk of tuberculosis transmission in a low-prevalence country.
    Opota O; Senn L; Prod'hom G; Mazza-Stalder J; Tissot F; Greub G; Jaton K
    Clin Microbiol Infect; 2016 Jul; 22(7):613-9. PubMed ID: 27139592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved performance of Xpert MTB/RIF assay on sputum sediment samples obtained from presumptive pulmonary tuberculosis cases at Kibong'oto infectious diseases hospital in Tanzania.
    Mbelele PM; Aboud S; Mpagama SG; Matee MI
    BMC Infect Dis; 2017 Dec; 17(1):808. PubMed ID: 29284421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of screening strategies for pulmonary tuberculosis among hospitalized patients in a low-burden setting: cost-effectiveness of GeneXpert MTB/RIF compared to smear microscopy.
    Hickey AJ; Cummings MJ; Zafari Z; Louh IK; Li J; O'Donnell MR
    Infect Control Hosp Epidemiol; 2022 Jul; 43(7):892-897. PubMed ID: 34154681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review: Comparison of Xpert MTB/RIF, LAMP and SAT methods for the diagnosis of pulmonary tuberculosis.
    Yan L; Xiao H; Zhang Q
    Tuberculosis (Edinb); 2016 Jan; 96():75-86. PubMed ID: 26786658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
    Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K
    Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals.
    Diel R; Nienhaus A; Hillemann D; Richter E
    Eur Respir J; 2016 Feb; 47(2):575-87. PubMed ID: 26647440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.
    Rachow A; Zumla A; Heinrich N; Rojas-Ponce G; Mtafya B; Reither K; Ntinginya EN; O'Grady J; Huggett J; Dheda K; Boehme C; Perkins M; Saathoff E; Hoelscher M
    PLoS One; 2011; 6(6):e20458. PubMed ID: 21738575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.